Works by Jayaprakasam, Vetri Sudar

Results: 12
    1
    2

    Patient metabolic profile defined by liver and muscle <sup>18</sup>F-FDG PET avidity is independently associated with overall survival in gastric cancer.

    Published in:
    Gastric Cancer, 2024, v. 27, n. 3, p. 548, doi. 10.1007/s10120-024-01485-7
    By:
    • Vitiello, Gerardo A.;
    • Jayaprakasam, Vetri Sudar;
    • Tang, Laura H.;
    • Schattner, Mark A.;
    • Janjigian, Yelena Y.;
    • Ku, Geoffrey Y.;
    • Maron, Steven B.;
    • Schoder, Heiko;
    • Larson, Steven M.;
    • Gönen, Mithat;
    • Datta, Jashodeep;
    • Coit, Daniel G.;
    • Brennan, Murray F.;
    • Strong, Vivian E.
    Publication type:
    Article
    3

    MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.

    Published in:
    European Radiology, 2022, v. 32, n. 2, p. 971, doi. 10.1007/s00330-021-08144-w
    By:
    • Jayaprakasam, Vetri Sudar;
    • Paroder, Viktoriya;
    • Gibbs, Peter;
    • Bajwa, Raazi;
    • Gangai, Natalie;
    • Sosa, Ramon E.;
    • Petkovska, Iva;
    • Golia Pernicka, Jennifer S.;
    • Fuqua III, James Louis;
    • Bates, David D. B.;
    • Weiser, Martin R.;
    • Cercek, Andrea;
    • Gollub, Marc J.
    Publication type:
    Article
    4

    Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 2, p. 325, doi. 10.1007/s00259-023-06420-z
    By:
    • Bodei, Lisa;
    • Michael Tuttle, R.;
    • Grewal, Ravinder K.;
    • Mauguen, Audrey;
    • Augensen, Finn;
    • Abusamra, Murad;
    • Mahajan, Sonia;
    • Jayaprakasam, Vetri Sudar;
    • Osborne, Joseph R.;
    • Haque, Sofia;
    • Wong, Bernadette Z. Y.;
    • Ghossein, Ronald A.;
    • Fagin, James;
    • Schӧder, Heiko;
    • Ho, Alan;
    • Humm, John L.;
    • Larson, Steven M.
    Publication type:
    Article
    5

    The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2971, doi. 10.1007/s00259-023-06240-1
    By:
    • Mauguen, Audrey;
    • Grewal, Ravinder K.;
    • Augensen, Finn;
    • Abusamra, Murad;
    • Mahajan, Sonia;
    • Jayaprakasam, Vetri Sudar;
    • Osborne, Joseph;
    • Haque, Sofia;
    • Wong, Bernadette Z. Y.;
    • Ghossein, Ronald A.;
    • Fagin, James;
    • Schӧder, Heiko;
    • Tuttle, R. Michael;
    • Ho, Alan;
    • Humm, John L.;
    • Larson, Steven M.
    Publication type:
    Article
    6
    7
    8

    PET/MRI in colorectal and anal cancers: an update.

    Published in:
    Abdominal Radiology, 2023, v. 48, n. 12, p. 3558, doi. 10.1007/s00261-023-03897-y
    By:
    • Jayaprakasam, Vetri Sudar;
    • Ince, Semra;
    • Suman, Garima;
    • Nepal, Pankaj;
    • Hope, Thomas A.;
    • Paspulati, Raj Mohan;
    • Fraum, Tyler J.
    Publication type:
    Article
    9

    Combined artificial intelligence and radiologist model for predicting rectal cancer treatment response from magnetic resonance imaging: an external validation study.

    Published in:
    Abdominal Radiology, 2022, v. 47, n. 8, p. 2770, doi. 10.1007/s00261-022-03572-8
    By:
    • Horvat, Natally;
    • Veeraraghavan, Harini;
    • Nahas, Caio S. R.;
    • Bates, ‬David D. B.;
    • Ferreira, Felipe R.;
    • Zheng, Junting;
    • Capanu, Marinela;
    • Fuqua III, James L.;
    • Fernandes, Maria Clara;
    • Sosa, Ramon E.;
    • Jayaprakasam, Vetri Sudar;
    • Cerri, Giovanni G.;
    • Nahas, Sergio C.;
    • Petkovska, Iva
    Publication type:
    Article
    10
    11

    First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 386, doi. 10.2967/jnumed.123.266392
    By:
    • Yeh, Randy;
    • O'Donoghue, Joseph A.;
    • Jayaprakasam, Vetri Sudar;
    • Mauguen, Audrey;
    • Min, Ryan;
    • Park, Sue;
    • Brockway, Julia P.;
    • Bromberg, Jacqueline F.;
    • Zhi, W. Iris;
    • Robson, Mark E.;
    • Sanford, Rachel;
    • Modi, Shanu;
    • Agnew, Brian J.;
    • Lyashchenko, Serge K.;
    • Lewis, Jason S.;
    • Ulaner, Gary A.;
    • Zeglis, Brian M.
    Publication type:
    Article
    12

    First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266392
    By:
    • Yeh, Randy;
    • O'Donoghue, Joseph A.;
    • Jayaprakasam, Vetri Sudar;
    • Mauguen, Audrey;
    • Min, Ryan;
    • Park, Sue;
    • Brockway, Julia P.;
    • Bromberg, Jacqueline F.;
    • Zhi, W. Iris;
    • Robson, Mark E.;
    • Sanford, Rachel;
    • Modi, Shanu;
    • Agnew, Brian J.;
    • Lyashchenko, Serge K.;
    • Lewis, Jason S.;
    • Ulaner, Gary A.;
    • Zeglis, Brian M.
    Publication type:
    Article